ProShare Advisors Portfolio holdings
AUM
$50.1B
1-Year Return
23.39%
This Quarter Return
-2.53%
1 Year Return
+23.39%
3 Year Return
+95.6%
5 Year Return
+167.57%
10 Year Return
+417.51%
AUM
$44.3B
AUM Growth
+$548M
(+1.3%)
Cap. Flow
+$2.39B
Cap. Flow
% of AUM
5.4%
Top 10 Holdings %
Top 10 Hldgs %
27.39%
Holding
2,291
New
20
Increased
497
Reduced
1,558
Closed
210
Top Buys
| 1 |
Apple
AAPL
|
$215M |
| 2 |
Eversource Energy
ES
|
$187M |
| 3 |
Microsoft
MSFT
|
$184M |
| 4 |
Erie Indemnity
ERIE
|
$182M |
| 5 |
Factset
FDS
|
$165M |
Top Sells
| 1 |
Cardinal Health
CAH
|
$48.8M |
| 2 |
Emerson Electric
EMR
|
$47.1M |
| 3 |
Walmart
WMT
|
$41.1M |
| 4 |
Williams-Sonoma
WSM
|
$36.2M |
| 5 |
IBM
IBM
|
$35.7M |
Sector Composition
| 1 | Technology | 30.94% |
| 2 | Consumer Staples | 10.31% |
| 3 | Consumer Discretionary | 10.1% |
| 4 | Financials | 9.92% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Forge Global Holdings
FRGE
$235M
| $14.3K | ﹤0.01% |
1,698
-489
| -22% | -$4.12K |
|
2052
Rekor Systems
REKR
$138M
| $14.1K | ﹤0.01% |
15,952
-4,800
| -23% | -$4.26K |
|
2053
Zura Bio
ZURA
$143M
| $14.1K | ﹤0.01% |
10,927
-2,967
| -21% | -$3.83K |
|
2054
Veru
VERU
$49.4M
| $14K | ﹤0.01% |
2,860
-860
| -23% | -$4.21K |
|
2055
Tevogen Bio Holdings
TVGN
$170M
| $14K | ﹤0.01% |
12,933
-1,747
| -12% | -$1.89K |
|
2056
Sutro Biopharma
STRO
$89.9M
| $14K | ﹤0.01% |
21,441
-5,520
| -20% | -$3.59K |
|
2057
Chegg
CHGG
$185M
| $13.9K | ﹤0.01% |
21,798
-6,562
| -23% | -$4.2K |
|
2058
Renovaro
RENB
$47.7M
| $13.3K | ﹤0.01% |
24,571
-7,999
| -25% | -$4.35K |
|
|
INZY
2059
DELISTED
Inozyme Pharma
INZY
| $13.2K | ﹤0.01% |
14,521
-3,286
| -18% | -$2.99K |
|
2060
Pyxis Oncology
PYXS
$118M
| $13.1K | ﹤0.01% |
13,361
-3,207
| -19% | -$3.14K |
|
2061
GrowGeneration
GRWG
$90.3M
| $13.1K | ﹤0.01% |
12,114
-3,646
| -23% | -$3.94K |
|
2062
FiscalNote
NOTE
$58.7M
| $12.9K | ﹤0.01% |
1,334
-138
| -9% | -$1.34K |
|
2063
Applied Therapeutics
APLT
$68.2M
| $12.9K | ﹤0.01% |
26,446
-6,142
| -19% | -$3K |
|
2064
Stem
STEM
$117M
| $11.5K | ﹤0.01% |
1,642
-496
| -23% | -$3.47K |
|
|
KG
2065
Kestrel Group, Ltd.
KG
$200M
| $11.1K | ﹤0.01% |
969
-271
| -22% | -$3.09K |
|
2066
LiveOne
LVO
$51.2M
| $11K | ﹤0.01% |
15,746
-5,364
| -25% | -$3.75K |
|
2067
Invivyd
IVVD
$239M
| $10.4K | ﹤0.01% |
17,168
-5,168
| -23% | -$3.13K |
|
2068
Mersana Therapeutics
MRSN
$34M
| $9.91K | ﹤0.01% |
1,151
-361
| -24% | -$3.11K |
|
2069
Purple Innovation
PRPL
$122M
| $9.35K | ﹤0.01% |
12,309
-3,707
| -23% | -$2.81K |
|
2070
Nautilus Biotechnolgy
NAUT
$83.5M
| $9.08K | ﹤0.01% |
10,546
-3,175
| -23% | -$2.73K |
|
2071
X4 Pharmaceuticals
XFOR
$78.6M
| $8.73K | ﹤0.01% |
1,231
-347
| -22% | -$2.46K |
|
|
AMRN
2072
Amarin Corp
AMRN
$317M
| $8.1K | ﹤0.01% |
903
-45
| -5% | -$403 |
|
2073
Tenaya Therapeutics
TNYA
$220M
| $6.81K | ﹤0.01% |
11,941
-3,499
| -23% | -$2K |
|
2074
LanzaTech
LNZA
$44.5M
| $5.86K | ﹤0.01% |
242
-73
| -23% | -$1.77K |
|
2075
Century Therapeutics
IPSC
$43.6M
| $4.82K | ﹤0.01% |
10,131
-3,049
| -23% | -$1.45K |
|